Onconetix Corporation (ONCO) Price to Earnings Ratio

Corporate emblem and logo of Onconetix Corp (ONCO)

Onconetix, Inc. (ONCO) is developing its business within the early detection niche for malignant prostate tumors by implementing precision diagnostic tools. This historical price chart featuring the -0.10 metric illustrates the dynamics of the company, which maintains its position through exclusive biomarker patents. The enterprise is currently expanding its commercial presence, offering up-to-date methods for detecting dangerous forms of cancer to improve men's health.

ONCO Onconetix: Price to Earnings Ratio in the range 02/21/2024 - 11/16/2026

Analytical breakdowns for Onconetix, Inc.

- price and consensus price forecast:
Comprehensive company analysis:ONCO (Onconetix Inc)
Manufactured product of Onconetix, Inc.

Investors are seeking fundamental value supports by analyzing the market capitalization to net income ratio. This coefficient determines the price per unit of earnings, making it possible to identify asset overvaluation. The P/E trajectory of Onconetix, Inc. (ONCO) visualizes the balance between market expectations and actual business efficiency. For Onconetix, Inc. (ONCO), this metric reflects the monetization potential of the drug Entadfi. This valuation helps determine whether the growth of the urological segment is currently priced into the share value.

Analysis of competing companies

Agilent (A) - Business Payback Period|Price to Earnings Ratio DGX (questdiagnostics.com)|Price to Earnings Ratio ILMN (Illumina, Inc.)|Exact Sciences Corp - Price to Earnings Ratio|revvity.com (RVTY) - Market Cap to Earnings|Bio-Rad Laboratories, Inc. - P/E Multiple|Business Payback Period Anbio NNNN|Nordion (SHC) - Price to Earnings Ratio|QDEL - Business Payback Period|Price to Earnings Ratio OPKO Health Inc|CareDx (CDNA) - Business Payback Period|Price to Earnings Ratio Maravai LifeSciences Holdings (MRVI)|FLGT: Market Cap to Net Income|P/E Multiple LAB (Standard BioTools Inc)|Cytek Biosciences, Inc. (CTKB) - Market Cap to Earnings|OraSure Corp - P/E Multiple|Market Cap to Net Income Ratio exagen.com (XGN)|MDXH: P/E Multiple|LUCD - Business Payback Period|Price to Earnings Ratio PRE|IMDX - Market Cap to Net Income Ratio|Price to Earnings Ratio TRIB (Trinity Biotech plc)|P/E Multiple prophaselabs.com (PRPH)|P/E Multiple AIMD (Ainos Inc)|Market Cap to Net Income Ratio Co-Diagnostics Inc|heartsciences.com - P/E Multiple|Biomerica, Inc (BMRA) - Price to Earnings Ratio|CDIO: P/E Multiple|Market Cap to Earnings viraxbiolabs.com (VRAX)|BJDX (Bluejay Diagnostics Inc) - P/E Multiple|Market Cap to Earnings Aspira Women's Health, Inc. AWH|Price to Earnings Ratio AXDX (Accelerate Diagnostics, Inc)|CENTOGENE, N.V. - Price to Earnings Multiple|Enzo Biochem, Inc. - Price to Earnings Ratio|FRES - Price to Earnings Ratio|GENE - Price to Earnings Ratio|Company Value to Net Income ME (23andMe)|PMD: P/E Multiple